IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors. Article excerpts from calcalisttech.com.
One in forty Ashkenazi Jews carry a BRCA genetic mutation, and carriers face an eighty percent chance of developing breast or ovarian cancer. Breast and ovarian cancers are the most common cancers afflicting women in the United States and Israel. Created to serve this population, Israel’s Rabin Medical Center is home to the BRCA Multidisciplinary Clinic at the Davidoff Cancer Center – a world class facility whose sole focus is on the treatment and prevention of cancer.
Serving patients from all over Israel, the Breast Cancer Unit at the Davidoff Center provides comprehensive care from the diagnostic stage through systemic treatment and radiation therapy. Over the past year, the Unit had 10,000 visits and 500 new patients.